186 related articles for article (PubMed ID: 28976288)
1. The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment.
Levran O; Peles E; Randesi M; da Rosa JC; Adelson M; Kreek MJ
Pharmacogenomics; 2017 Oct; 18(15):1387-1391. PubMed ID: 28976288
[TBL] [Abstract][Full Text] [Related]
2. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response.
Xie X; Gu J; Zhuang D; Zhou Y; Chen X; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H
J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091
[TBL] [Abstract][Full Text] [Related]
3. Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1.
Hancock DB; Levy JL; Gaddis NC; Glasheen C; Saccone NL; Page GP; Hulse GK; Wildenauer D; Kelty EA; Schwab SG; Degenhardt L; Martin NG; Montgomery GW; Attia J; Holliday EG; McEvoy M; Scott RJ; Bierut LJ; Nelson EC; Kral AH; Johnson EO
Biol Psychiatry; 2015 Oct; 78(7):474-84. PubMed ID: 25744370
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in genes of the stress response pathway are associated with prolonged abstinence from heroin.
Levran O; Peles E; Randesi M; Correa da Rosa J; Shen PH; Rotrosen J; Adelson M; Kreek MJ
Pharmacogenomics; 2018 Mar; 19(4):333-341. PubMed ID: 29465008
[TBL] [Abstract][Full Text] [Related]
5. No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample.
Nikolov MA; Beltcheva O; Galabova A; Ljubenova A; Jankova E; Gergov G; Russev AA; Lynskey MT; Nelson EC; Nesheva E; Krasteva D; Lazarov P; Mitev VI; Kremensky IM; Kaneva RP; Todorov AA
Drug Alcohol Depend; 2011 Aug; 117(1):62-5. PubMed ID: 21277709
[TBL] [Abstract][Full Text] [Related]
6. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.
Haerian BS; Haerian MS
Pharmacogenomics; 2013 May; 14(7):813-24. PubMed ID: 23651028
[TBL] [Abstract][Full Text] [Related]
7. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin.
Shi J; Hui L; Xu Y; Wang F; Huang W; Hu G
Hum Mutat; 2002 Apr; 19(4):459-60. PubMed ID: 11933204
[TBL] [Abstract][Full Text] [Related]
8. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage.
Zhang Q; Shi M; Tang H; Zhong H; Lu X
Genet Test Mol Biomarkers; 2020 Jan; 24(1):17-23. PubMed ID: 31940240
[No Abstract] [Full Text] [Related]
9. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
Bond C; LaForge KS; Tian M; Melia D; Zhang S; Borg L; Gong J; Schluger J; Strong JA; Leal SM; Tischfield JA; Kreek MJ; Yu L
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9608-13. PubMed ID: 9689128
[TBL] [Abstract][Full Text] [Related]
10. Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.
Woodcock EA; Lundahl LH; Burmeister M; Greenwald MK
Am J Addict; 2015 Jun; 24(4):329-35. PubMed ID: 25911999
[TBL] [Abstract][Full Text] [Related]
11. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.
Xu J; Lu Z; Xu M; Pan L; Deng Y; Xie X; Liu H; Ding S; Hurd YL; Pasternak GW; Klein RJ; Cartegni L; Zhou W; Pan YX
J Neurosci; 2014 Aug; 34(33):11048-66. PubMed ID: 25122903
[TBL] [Abstract][Full Text] [Related]
12. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts.
Nielsen DA; Yuferov V; Hamon S; Jackson C; Ho A; Ott J; Kreek MJ
Neuropsychopharmacology; 2009 Mar; 34(4):867-73. PubMed ID: 18650805
[TBL] [Abstract][Full Text] [Related]
13. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
[TBL] [Abstract][Full Text] [Related]
15. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
Kumar D; Chakraborty J; Das S
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):225-30. PubMed ID: 22138325
[TBL] [Abstract][Full Text] [Related]
16. A single nucleotide polymorphism in
Koijam AS; Chakraborty B; Mukhopadhyay K; Rajamma U; Haobam R
J Addict Dis; 2020; 38(2):214-222. PubMed ID: 32189578
[TBL] [Abstract][Full Text] [Related]
17. Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.
Clarke TK; Crist RC; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Ferraro TN; Lohoff FW; Berrettini WH
Neurosci Lett; 2013 May; 542():71-5. PubMed ID: 23454283
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.
Smith AH; Jensen KP; Li J; Nunez Y; Farrer LA; Hakonarson H; Cook-Sather SD; Kranzler HR; Gelernter J
Mol Psychiatry; 2017 Mar; 22(3):346-352. PubMed ID: 28115739
[TBL] [Abstract][Full Text] [Related]
19. Genetic-epigenetic interaction modulates μ-opioid receptor regulation.
Oertel BG; Doehring A; Roskam B; Kettner M; Hackmann N; Ferreirós N; Schmidt PH; Lötsch J
Hum Mol Genet; 2012 Nov; 21(21):4751-60. PubMed ID: 22875838
[TBL] [Abstract][Full Text] [Related]
20. Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers.
Drakenberg K; Nikoshkov A; Horváth MC; Fagergren P; Gharibyan A; Saarelainen K; Rahman S; Nylander I; Bakalkin G; Rajs J; Keller E; Hurd YL
Proc Natl Acad Sci U S A; 2006 May; 103(20):7883-8. PubMed ID: 16682632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
